{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:29:28Z","timestamp":1761514168258},"reference-count":314,"publisher":"Elsevier","isbn-type":[{"value":"9780323508780","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-323-50878-0.00014-8","type":"book-chapter","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T15:25:26Z","timestamp":1520609126000},"page":"399-448","source":"Crossref","is-referenced-by-count":3,"title":["Functional Moieties for Intracellular Traffic of Nanomaterials"],"prefix":"10.1016","author":[{"given":"Ana L.","family":"Silva","sequence":"first","affiliation":[]},{"given":"Liane I.F.","family":"Moura","sequence":"additional","affiliation":[]},{"given":"B\u00e1rbara","family":"Carreira","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Conniot","sequence":"additional","affiliation":[]},{"given":"Ana I.","family":"Matos","sequence":"additional","affiliation":[]},{"given":"Carina","family":"Peres","sequence":"additional","affiliation":[]},{"given":"Vanessa","family":"Sainz","sequence":"additional","affiliation":[]},{"given":"Liana C.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Rog\u00e9rio S.","family":"Gaspar","sequence":"additional","affiliation":[]},{"given":"Helena F.","family":"Florindo","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejca.2004.12.021","article-title":"Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology","volume":"41","author":"Abel","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/pj.2012.215","article-title":"Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors","volume":"45","author":"Accardo","year":"2013","journal-title":"Polym. J."},{"issue":"29","key":"10.1016\/B978-0-323-50878-0.00014-8_bib3","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1016\/j.biomaterials.2009.07.008","article-title":"Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy","volume":"30","author":"Acharya","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib4","series-title":"Engineering of Nanobiomaterials","first-page":"1","article-title":"Chapter 1-Engineering of stimuli-sensitive nanopreparations to overcome physiological barriers and cancer multidrug resistance","author":"A\u011fardan","year":"2016"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-50878-0.00014-8_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2007.09.024","article-title":"Ligand based dendritic systems for tumor targeting","volume":"350","author":"Agarwal","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2012.03.015","article-title":"siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat","volume":"161","author":"Al Soraj","year":"2012","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/B978-0-323-50878-0.00014-8_bib7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1358\/dot.1999.35.12.564040","article-title":"Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer","volume":"35","author":"Albanell","year":"1999","journal-title":"Drugs Today (Barc.)"},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib9","series-title":"Intracellular Delivery II: Fundamentals and Applications","first-page":"117","article-title":"Uptake and intracellular trafficking of nanocarriers","author":"Andersen","year":"2014"},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib10","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C","article-title":"Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway","volume":"30","author":"Apostolopoulos","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/bi00052a012","article-title":"Membrane translocation of diphtheria toxin A-fragment: role of carboxy-terminal region","volume":"32","author":"Ariansen","year":"1993","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/mrm.10406","article-title":"MR molecular imaging of the Her-2\/neu receptor in breast cancer cells using targeted iron oxide nanoparticles","volume":"49","author":"Artemov","year":"2003","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2014.01.107","article-title":"Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery","volume":"444","author":"Asai","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.09.074","article-title":"Drug targeting and tumor heterogeneity","volume":"133","author":"Bae","year":"2009","journal-title":"J. Control. Release"},{"issue":"48","key":"10.1016\/B978-0-323-50878-0.00014-8_bib15","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1002\/anie.200602251","article-title":"An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform","volume":"45","author":"Bagalkot","year":"2006","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"10","key":"10.1016\/B978-0-323-50878-0.00014-8_bib16","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/nl071546n","article-title":"Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer","volume":"7","author":"Bagalkot","year":"2007","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ijc.20452","article-title":"Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells","volume":"112","author":"Banerjee","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","article-title":"Endocytic mechanisms for targeted drug delivery","volume":"59","author":"Bareford","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yexmp.2009.01.004","article-title":"Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer","volume":"86","author":"Bates","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"10","key":"10.1016\/B978-0-323-50878-0.00014-8_bib20","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1021\/nl102172j","article-title":"Rapid cytosolic delivery of luminescent nanocrystals in live cells with endosome-disrupting polymer colloids","volume":"10","author":"Bayles","year":"2010","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3816\/CGC.2006.n.012","article-title":"Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design","volume":"4","author":"Beekman","year":"2006","journal-title":"Clin. Genitourin. Cancer"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-50878-0.00014-8_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2533\/chimia.1997.34","article-title":"The proton sponge: a trick to enter cells the viruses did not exploit","volume":"51","author":"Behr","year":"1997","journal-title":"CHIMIA Int. J. Chem."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2013.02.020","article-title":"Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer","volume":"335","author":"Biswas","year":"2013","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejpb.2012.12.021","article-title":"Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity","volume":"84","author":"Biswas","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2012.01.009","article-title":"Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in\u00a0vitro and in\u00a0vivo","volume":"159","author":"Biswas","year":"2012","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/B978-0-323-50878-0.00014-8_bib26","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1016\/j.biomaterials.2012.03.032","article-title":"Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria","volume":"33","author":"Biswas","year":"2012","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/B978-0-323-50878-0.00014-8_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/1061186X.2010.536983","article-title":"Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting","volume":"19","author":"Biswas","year":"2011","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib28","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1021\/nl801908y","article-title":"Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Boddapati","year":"2008","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.20032220","article-title":"In\u00a0vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination","volume":"199","author":"Bonifaz","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.010909.105547","article-title":"Discovery and development of therapeutic aptamers","volume":"50","author":"Bouchard","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/B978-0-323-50878-0.00014-8_bib31","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.addr.2004.02.014","article-title":"Nanoparticle and targeted systems for cancer therapy","volume":"56","author":"Brannon-Peppas","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"23","key":"10.1016\/B978-0-323-50878-0.00014-8_bib32","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1021\/ja043042m","article-title":"Polymer micelle with cross-linked ionic core","volume":"127","author":"Bronich","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/exd.12285","article-title":"Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells","volume":"23","author":"Buhl","year":"2014","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2009.04.035","article-title":"Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier","volume":"379","author":"Chang","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/1061186X.2015.1108324","article-title":"Smart linkers in polymer\u2013drug conjugates for tumor-targeted delivery","volume":"24","author":"Chang","year":"2016","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0169-409X(02)00026-1","article-title":"PEGylated antibodies and antibody fragments for improved therapy: a review","volume":"54","author":"Chapman","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/11717","article-title":"Therapeutic antibody fragments with prolonged in\u00a0vivo half-lives","volume":"17","author":"Chapman","year":"1999","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib38","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/mp100207t","article-title":"Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer","volume":"7","author":"Chattopadhyay","year":"2010","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2008.03.010","article-title":"Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy","volume":"128","author":"Chen","year":"2008","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mser.2013.03.001","article-title":"Nanoparticles for improving cancer diagnosis","volume":"74","author":"Chen","year":"2013","journal-title":"Mater. Sci. Eng. R. Rep."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2008.08.006","article-title":"Galactose-poly(ethylene glycol)-polyethylenimine for improved lung gene transfer","volume":"375","author":"Chen","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"18","key":"10.1016\/B978-0-323-50878-0.00014-8_bib42","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1073\/pnas.84.18.6471","article-title":"Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor","volume":"84","author":"Cheresh","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jconrel.2004.03.019","article-title":"Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine","volume":"97","author":"Chiu","year":"2004","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1039\/C0CS00003E","article-title":"Strategies for the intracellular delivery of nanoparticles","volume":"40","author":"Chou","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib45","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/bc0602026","article-title":"Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery","volume":"17","author":"Christensen","year":"2006","journal-title":"Bioconjug. Chem."},{"issue":"11","key":"10.1016\/B978-0-323-50878-0.00014-8_bib46","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/acs.biomac.6b01056","article-title":"Self-assembled peptide-based system for mitochondrial-targeted gene delivery: functional and structural insights","volume":"17","author":"Chuah","year":"2016","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma(1) receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2008.08.025","article-title":"An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site","volume":"381","author":"Cohen","year":"2008","journal-title":"Virology"},{"issue":"9\u201310","key":"10.1016\/B978-0-323-50878-0.00014-8_bib49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0264-410X(02)00536-4","article-title":"Liposomal delivery of antigen to human dendritic cells","volume":"21","author":"Copland","year":"2003","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/B978-0-323-50878-0.00014-8_bib50","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jmmm.2010.02.019","article-title":"Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells","volume":"322","author":"Creixell","year":"2010","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2014.07.040","article-title":"Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study","volume":"192","author":"Cruz","year":"2014","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2010.02.013","article-title":"Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in\u00a0vitro","volume":"144","author":"Cruz","year":"2010","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib53","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1023\/B:PHAM.0000029292.66792.4f","article-title":"Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor","volume":"21","author":"Cui","year":"2004","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1081\/DDC-120021318","article-title":"Physical characterization and macrophage cell uptake of mannan-coated nanoparticles","volume":"29","author":"Cui","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib55","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.mito.2005.07.001","article-title":"Mitochondrial leader sequence\u2013plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria","volume":"5","author":"D\u2019Souza","year":"2005","journal-title":"Mitochondrion"},{"issue":"7","key":"10.1016\/B978-0-323-50878-0.00014-8_bib56","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/10611860802228855","article-title":"Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel","volume":"16","author":"D\u2019Souza","year":"2008","journal-title":"J. Drug Target."},{"issue":"1\u20132","key":"10.1016\/B978-0-323-50878-0.00014-8_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-3659(03)00297-9","article-title":"DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells","volume":"92","author":"D\u2019Souza","year":"2003","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib58","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4049\/jimmunol.176.1.426","article-title":"Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses","volume":"176","author":"Dakappagari","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib59","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/nn300296p","article-title":"Direct observation of nanoparticle-cancer cell nucleus interactions","volume":"6","author":"Dam","year":"2012","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/15257770.2013.776078","article-title":"PEGylated and non-PEGylated siRNA lipoplexes formulated with cholesteryl cytofectins promote efficient luciferase knockdown in HeLa tat luc cells","volume":"32","author":"Daniels","year":"2013","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clim.2006.06.006","article-title":"The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0300-9084(86)80004-9","article-title":"Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor","volume":"68","author":"Dautry-Varsat","year":"1986","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib64","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/mp900015y","article-title":"The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic","volume":"6","author":"Davis","year":"2009","journal-title":"Mol. Pharm."},{"issue":"27","key":"10.1016\/B978-0-323-50878-0.00014-8_bib65","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1074\/jbc.274.27.19087","article-title":"Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells","volume":"274","author":"Diebold","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib66","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib67","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/nl062962v","article-title":"Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods","volume":"7","author":"Durr","year":"2007","journal-title":"Nano Lett."},{"issue":"Pt 22","key":"10.1016\/B978-0-323-50878-0.00014-8_bib68","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1242\/jcs.03238","article-title":"Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events","volume":"119","author":"Falcone","year":"2006","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0005-2736(95)80016-9","article-title":"The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer","volume":"1235","author":"Farhood","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.peptides.2014.04.015","article-title":"Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules","volume":"57","author":"Farkhani","year":"2014","journal-title":"Peptides"},{"issue":"16","key":"10.1016\/B978-0-323-50878-0.00014-8_bib71","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1073\/pnas.0601755103","article-title":"Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in\u00a0vivo","volume":"103","author":"Farokhzad","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"21","key":"10.1016\/B978-0-323-50878-0.00014-8_bib72","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1158\/0008-5472.CAN-04-2550","article-title":"Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells","volume":"64","author":"Farokhzad","year":"2004","journal-title":"Cancer Res."},{"issue":"Suppl. 3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000088479","article-title":"VEGF as a therapeutic target in cancer","volume":"69","author":"Ferrara","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib74","series-title":"Intracellular Delivery: Fundamentals and Applications","first-page":"3","article-title":"Mass transport via cellular barriers and endocytosis","author":"Ferrati","year":"2011"},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib75","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00216-007-1470-1","article-title":"DNA aptamers against the MUC1 tumour marker: design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours","volume":"390","author":"Ferreira","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib76","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","article-title":"Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors","volume":"173","author":"Fifis","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/mp900201v","article-title":"Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy","volume":"7","author":"Fonge","year":"2010","journal-title":"Mol. Pharm."},{"issue":"35","key":"10.1016\/B978-0-323-50878-0.00014-8_bib78","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.2174\/13816128113199990375","article-title":"The smart targeting of nanoparticles","volume":"19","author":"Friedman","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib79","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/bc049864q","article-title":"Poly(3-guanidinopropyl methacrylate): a novel cationic polymer for gene delivery","volume":"15","author":"Funhoff","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib80","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biomaterials.2015.04.022","article-title":"Mitochondrial delivery of antisense RNA by MITO-Porter results in mitochondrial RNA knockdown, and has a functional impact on mitochondria","volume":"57","author":"Furukawa","year":"2015","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"60","key":"10.1016\/B978-0-323-50878-0.00014-8_bib82","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1039\/c4cc03793f","article-title":"Targeting lysosomal membrane permeabilization to induce and image apoptosis in cancer cells by multifunctional Au-ZnO hybrid nanoparticles","volume":"50","author":"Gao","year":"2014","journal-title":"Chem. Commun. (Camb.)"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib83","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/smll.201301673","article-title":"Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier","volume":"10","author":"Gao","year":"2014","journal-title":"Small"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib84","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2147\/IJN.S17040","article-title":"Research progress on siRNA delivery with nonviral carriers","volume":"6","author":"Gao","year":"2011","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib85","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00216-011-4756-2","article-title":"Supramolecular complexes of quantum dots and a polyamidoamine (PAMAM)-folate derivative for molecular imaging of cancer cells","volume":"400","author":"Geraldo","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0885328213515288","article-title":"Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: a promising carrier for mitoxantrone","volume":"29","author":"Ghanbarzadeh","year":"2014","journal-title":"J. Biomater. Appl."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib87","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/1061186X.2010.499463","article-title":"Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles","volume":"19","author":"Ghotbi","year":"2011","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib88","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.copbio.2006.10.003","article-title":"Biopharmaceutical drug discovery using novel protein scaffolds","volume":"17","author":"Gill","year":"2006","journal-title":"Curr. Opin. Biotechnol."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib89","first-page":"1949","article-title":"Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump","volume":"6","author":"Goren","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"5153","key":"10.1016\/B978-0-323-50878-0.00014-8_bib90","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"issue":"10","key":"10.1016\/B978-0-323-50878-0.00014-8_bib91","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.molmed.2007.08.002","article-title":"TAT transduction: the molecular mechanism and therapeutic prospects","volume":"13","author":"Gump","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"9","key":"10.1016\/B978-0-323-50878-0.00014-8_bib92","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s11095-011-0459-9","article-title":"Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles","volume":"28","author":"Hamdy","year":"2011","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7243\/2052-9341-4-2","article-title":"Platinum-based anticancer drugs encapsulated liposome and polymeric micelle formulation in clinical trials","volume":"4","author":"Hang","year":"2016","journal-title":"Biochem. Compd."},{"issue":"16","key":"10.1016\/B978-0-323-50878-0.00014-8_bib94","doi-asserted-by":"crossref","first-page":"164207","DOI":"10.1088\/0953-8984\/24\/16\/164207","article-title":"Caveolae-mediated endocytosis of biocompatible gold nanoparticles in living Hela cells","volume":"24","author":"Hao","year":"2012","journal-title":"J. Phys. Condens Matter"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib95","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/bm700535p","article-title":"Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells","volume":"9","author":"Harush-Frenkel","year":"2008","journal-title":"Biomacromolecules"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib96","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addr.2010.09.001","article-title":"A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma","volume":"63","author":"Hatakeyama","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib97","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1529\/biophysj.105.068692","article-title":"Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides","volume":"89","author":"Herbig","year":"2005","journal-title":"Biophys. J."},{"issue":"11","key":"10.1016\/B978-0-323-50878-0.00014-8_bib98","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1021\/mp400315p","article-title":"Active targeting of block copolymer micelles with trastuzumab Fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER2-overexpressing xenografts","volume":"10","author":"Hoang","year":"2013","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib99","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/bm201479t","article-title":"Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells","volume":"13","author":"Hoang","year":"2012","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.nano.2011.08.014","article-title":"Enhanced delivery of alpha-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders","volume":"8","author":"Hsu","year":"2012","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib101","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2010.10.031","article-title":"Enhanced endothelial delivery and biochemical effects of alpha-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease","volume":"149","author":"Hsu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib102","article-title":"An artemisinin-mediated ROS evolving and dual protease light-up nanocapsule for real-time imaging of lysosomal tumor cell death","author":"Huang","year":"2016","journal-title":"Biosens. Bioelectron."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib103","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1096\/fj.06-7380com","article-title":"Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer","volume":"21","author":"Huang","year":"2007","journal-title":"FASEB J."},{"issue":"21","key":"10.1016\/B978-0-323-50878-0.00014-8_bib104","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1016\/j.biomaterials.2013.03.043","article-title":"Tumor targeting and microenvironment-responsive nanoparticles for gene delivery","volume":"34","author":"Huang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib105","article-title":"Modularized gold nanocarriers for tat-mediated delivery of siRNA","author":"Huang","year":"2016","journal-title":"Small"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib106","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.109.069880","article-title":"A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer","volume":"51","author":"Hwang","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/B978-0-323-50878-0.00014-8_bib107","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1039\/C4CP04301D","article-title":"Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications","volume":"17","author":"Imani","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib108","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nantod.2011.02.003","article-title":"Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies","volume":"6","author":"Iversen","year":"2011","journal-title":"Nano Today"},{"issue":"17\u201318","key":"10.1016\/B978-0-323-50878-0.00014-8_bib109","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.drudis.2006.07.005","article-title":"Exploiting the enhanced permeability and retention effect for tumor targeting","volume":"11","author":"Iyer","year":"2006","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","article-title":"Barriers to drug delivery in solid tumors","volume":"271","author":"Jain","year":"1994","journal-title":"Sci. Am."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib111","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08982100600992302","article-title":"Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization","volume":"16","author":"Jain","year":"2006","journal-title":"J. Liposome Res."},{"issue":"284","key":"10.1016\/B978-0-323-50878-0.00014-8_bib112","first-page":"2","article-title":"FDA approves new kind of lymphoma treatment. Food and Drug Administration","author":"James","year":"1997","journal-title":"AIDS Treat. News"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/17425247.2015.1086745","article-title":"Intracellular delivery of nanocarriers and targeting to subcellular organelles","volume":"13","author":"Jhaveri","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib114","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1021\/bc0701186","article-title":"Degradable-brushed pHEMA-pDMAEMA synthesized via ATRP and click chemistry for gene delivery","volume":"18","author":"Jiang","year":"2007","journal-title":"Bioconjug. Chem."},{"issue":"1\u20136","key":"10.1016\/B978-0-323-50878-0.00014-8_bib115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12645-010-0009-x","article-title":"Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging","volume":"1","author":"Jin","year":"2010","journal-title":"Cancer Nanotechnol."},{"issue":"18","key":"10.1016\/B978-0-323-50878-0.00014-8_bib116","first-page":"4578","article-title":"Targeting sigma receptor-binding benzamides as in\u00a0vivo diagnostic and therapeutic agents for human prostate tumors","volume":"59","author":"John","year":"1999","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib117","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/smll.201002291","article-title":"Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor","volume":"7","author":"Jokerst","year":"2011","journal-title":"Small"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib118","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1208\/s12248-012-9418-6","article-title":"Biodegradable particles as vaccine delivery systems: size matters","volume":"15","author":"Joshi","year":"2013","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib119","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biomaterials.2008.09.042","article-title":"The conjugation of diphtheria toxin T domain to poly(ethylenimine) based vectors for enhanced endosomal escape during gene transfection","volume":"30","author":"Kakimoto","year":"2009","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bmcl.2012.11.015","article-title":"Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles","volume":"23","author":"Kasten","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/B978-0-323-50878-0.00014-8_bib121","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib122","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2011.08.012","article-title":"Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery","volume":"156","author":"Khalil","year":"2011","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib123","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib124","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2009.07.005","article-title":"Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice","volume":"140","author":"Kim","year":"2009","journal-title":"J. Control. Release"},{"issue":"46","key":"10.1016\/B978-0-323-50878-0.00014-8_bib125","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1002\/anie.200602471","article-title":"Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy","volume":"45","author":"Kim","year":"2006","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib126","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.mt.6300168","article-title":"Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I","volume":"15","author":"Kim","year":"2007","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib127","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jhep.2008.10.029","article-title":"Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes","volume":"50","author":"Kim","year":"2009","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2011.08.014","article-title":"Nanoparticle delivery of a peptide targeting EGFR signaling","volume":"157","author":"Kim","year":"2012","journal-title":"J. Control. Release"},{"issue":"13","key":"10.1016\/B978-0-323-50878-0.00014-8_bib129","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","article-title":"Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models","volume":"66","author":"Kirpotin","year":"2006","journal-title":"Cancer Res."},{"issue":"42","key":"10.1016\/B978-0-323-50878-0.00014-8_bib130","doi-asserted-by":"crossref","first-page":"17939","DOI":"10.1073\/pnas.1011368107","article-title":"Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy","volume":"107","author":"Kolishetti","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib131","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4161\/cbt.13.1.18871","article-title":"Increased apoptosis in cancer cells in\u00a0vitro and in\u00a0vivo by ceramides in transferrin-modified liposomes","volume":"13","author":"Koshkaryev","year":"2012","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib132","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.canlet.2012.06.008","article-title":"Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition","volume":"334","author":"Koshkaryev","year":"2013","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib133","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3109\/1061186X.2010.550921","article-title":"Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B","volume":"19","author":"Koshkaryev","year":"2011","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajps.2013.07.001","article-title":"The endocytosis and intracellular fate of nanomedicines: implication for rational design","volume":"8","author":"Kou","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib135","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cyto.a.20756","article-title":"The density of GM1-enriched lipid rafts correlates inversely with the efficiency of transfection mediated by cationic liposomes","volume":"75","author":"Kovacs","year":"2009","journal-title":"Cytom. A"},{"issue":"17","key":"10.1016\/B978-0-323-50878-0.00014-8_bib136","first-page":"3852","article-title":"Up-regulation of flk-1\/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system","volume":"57","author":"Kremer","year":"1997","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/B978-0-323-50878-0.00014-8_bib137","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-04-3921","article-title":"Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer","volume":"65","author":"Kukowska-Latallo","year":"2005","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/B978-0-323-50878-0.00014-8_bib138","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.biomaterials.2011.01.048","article-title":"Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor","volume":"32","author":"Kuo","year":"2011","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-50878-0.00014-8_bib139","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0168-3659(01)00426-6","article-title":"A new gene delivery formulation of polyethylenimine\/DNA complexes coated with PEG conjugated fusogenic peptide","volume":"76","author":"Lee","year":"2001","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2008.11.029","article-title":"Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice","volume":"378","author":"Lee","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Database issue","key":"10.1016\/B978-0-323-50878-0.00014-8_bib141","doi-asserted-by":"crossref","first-page":"D95","DOI":"10.1093\/nar\/gkh094","article-title":"Aptamer database","volume":"32","author":"Lee","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib142","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cbpa.2006.03.015","article-title":"Aptamer therapeutics advance","volume":"10","author":"Lee","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib143","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/adhm.201300613","article-title":"Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells","volume":"3","author":"Li","year":"2014","journal-title":"Adv. Healthc. Mater."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib144","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1039\/B920865H","article-title":"Directed evolution of gold nanoparticle delivery to cells","volume":"46","author":"Li","year":"2010","journal-title":"Chem. Commun. (Camb.)"},{"issue":"22","key":"10.1016\/B978-0-323-50878-0.00014-8_bib145","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1039\/c1ob05886j","article-title":"The influence of cyclodextrin modification on cellular uptake and transfection efficiency of polyplexes","volume":"9","author":"Li","year":"2011","journal-title":"Org. Biomol. Chem."},{"issue":"14","key":"10.1016\/B978-0-323-50878-0.00014-8_bib146","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1096\/fj.05-4058com","article-title":"Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib147","first-page":"699","article-title":"Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide","volume":"80","author":"Liao","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib148","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M116.762377","article-title":"Sphingosine and sphingosine kinase 1 involvement in endocytic membrane trafficking","author":"Lima","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib149","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/bc060200l","article-title":"Novel bioreducible poly(amido amine)s for highly efficient gene delivery","volume":"18","author":"Lin","year":"2007","journal-title":"Bioconjug. Chem."},{"issue":"29","key":"10.1016\/B978-0-323-50878-0.00014-8_bib150","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1016\/j.biomaterials.2011.05.089","article-title":"Dual docetaxel\/mfor both targeting magnetic resonance imaging and cancer therapy","volume":"32","author":"Ling","year":"2011","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib151","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1021\/mp200402e","article-title":"Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody","volume":"8","author":"Liu","year":"2011","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib152","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1039\/C5NR00072F","article-title":"Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in\u00a0vitro and in\u00a0vivo","volume":"7","author":"Liu","year":"2015","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib153","first-page":"551","article-title":"Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma","volume":"21","author":"Liu","year":"2010","journal-title":"J. Mater. Sci."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib154","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.biomaterials.2013.10.020","article-title":"Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas","volume":"35","author":"Liu","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/nn700040t","article-title":"Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery","volume":"1","author":"Liu","year":"2007","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/B978-0-323-50878-0.00014-8_bib156","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.biomaterials.2008.01.031","article-title":"An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection","volume":"29","author":"Lo","year":"2008","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib157","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0169-409X(02)00042-X","article-title":"Folate-mediated delivery of macromolecular anticancer therapeutic agents","volume":"54","author":"Lu","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib158","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/mp070058l","article-title":"Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells","volume":"4","author":"Lu","year":"2007","journal-title":"Mol. Pharm."},{"issue":"14","key":"10.1016\/B978-0-323-50878-0.00014-8_bib159","first-page":"4029","article-title":"Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen","volume":"62","author":"Lupold","year":"2002","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/B978-0-323-50878-0.00014-8_bib160","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1007\/s11095-011-0544-0","article-title":"Expression of GFP in the mitochondrial compartment using DQAsome-mediated delivery of an artificial mini-mitochondrial genome","volume":"28","author":"Lyrawati","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib161","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2016.04.026","article-title":"Future of nanotherapeutics: targeting the cellular sub-organelles","volume":"97","author":"Ma","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib162","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv. Enzyme Regul."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib163","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/micc.12228","article-title":"A retrospective 30 years after discovery of the enhanced permeability and retention effect of solid tumors: next-generation chemotherapeutics and photodynamic therapy\u2013problems, solutions, and prospects","volume":"23","author":"Maeda","year":"2016","journal-title":"Microcirculation"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib164","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbamem.2011.11.020","article-title":"The role of endocytosis on the uptake kinetics of luciferin-conjugated cell-penetrating peptides","volume":"1818","author":"Mager","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib165","first-page":"2041","article-title":"Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA","volume":"8","author":"Malhotra","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"24","key":"10.1016\/B978-0-323-50878-0.00014-8_bib166","doi-asserted-by":"crossref","first-page":"11631","DOI":"10.1158\/0008-5472.CAN-05-1093","article-title":"Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in\u00a0vivo","volume":"65","author":"Mamot","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib167","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.imlet.2014.07.008","article-title":"Effective induction of anti-tumor immunity using p5 HER-2\/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN","volume":"162","author":"Mansourian","year":"2014","journal-title":"Immunol. Lett."},{"issue":"40","key":"10.1016\/B978-0-323-50878-0.00014-8_bib168","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.1073\/pnas.1210096109","article-title":"Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics","volume":"109","author":"Marrache","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib169","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1208\/aapsj0901003","article-title":"Peptide-guided gene delivery","volume":"9","author":"Martin","year":"2007","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib170","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.22007","article-title":"Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in\u00a0vitro PDT studies","volume":"99","author":"Master","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/B978-0-323-50878-0.00014-8_bib171","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2217\/nnm.12.160","article-title":"EGF receptor-targeted nanocarriers for enhanced cancer treatment","volume":"7","author":"Master","year":"2012","journal-title":"Nanomedicine (Lond.)"},{"issue":"30","key":"10.1016\/B978-0-323-50878-0.00014-8_bib172","doi-asserted-by":"crossref","first-page":"27135","DOI":"10.1074\/jbc.M200429200","article-title":"Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins","volume":"277","author":"Mastrobattista","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"12 Pt 1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib173","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib174","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bbrc.2007.08.112","article-title":"Efficient generation of antigen-specific cellular immunity by vaccination with poly(gamma-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptides","volume":"362","author":"Matsuo","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib176","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/B978-0-12-416020-0.00014-0","article-title":"Cell delivery of therapeutic nanoparticles","volume":"104","author":"McMillan","year":"2011","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib177","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.addr.2007.06.009","article-title":"\u201cAlternative\u201d endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?","volume":"59","author":"Medina-Kauwe","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib178","first-page":"99","article-title":"Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer","volume":"4","author":"Miele","year":"2009","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib179","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/mp1002653","article-title":"Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel\/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells","volume":"8","author":"Milane","year":"2011","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/B978-0-323-50878-0.00014-8_bib180","doi-asserted-by":"crossref","first-page":"e24075","DOI":"10.1371\/journal.pone.0024075","article-title":"Therapeutic efficacy and safety of paclitaxel\/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer","volume":"6","author":"Milane","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/B978-0-323-50878-0.00014-8_bib181","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jgm.973","article-title":"A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA","volume":"8","author":"Min","year":"2006","journal-title":"J. Gene Med."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib182","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10611860600612953","article-title":"Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles","volume":"14","author":"Mishra","year":"2006","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib183","first-page":"107","article-title":"AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia","volume":"12","author":"Mongelard","year":"2010","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib184","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1179\/joc.2011.23.2.59","article-title":"Albumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancers","volume":"23","author":"Montana","year":"2011","journal-title":"J. Chemother."},{"issue":"27","key":"10.1016\/B978-0-323-50878-0.00014-8_bib185","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1073\/pnas.0803728105","article-title":"Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis","volume":"105","author":"Murphy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib186","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10517-008-0135-1","article-title":"Role of epidermal growth factor gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of pancreatic carcinoma","volume":"145","author":"Muslimov","year":"2008","journal-title":"Bull. Exp. Biol. Med."},{"issue":"10","key":"10.1016\/B978-0-323-50878-0.00014-8_bib187","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib188","series-title":"CT-322 in Treating Patients with Recurrent Glioblastoma Multiforme and Combination Therapy with Irinotecan","author":"NCT00562419","year":"2007"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib189","series-title":"Ph II of a Novel Anti-Angiogenic Agent in Combination with Chemotherapy for the Treatment of Non-Small Cell Lung Cancer","author":"NCT00850577","year":"2009"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib190","series-title":"Ph II Trial of a Novel Anti-Angiogenic Agent in Combination with Chemotherapy for the Second-Line Treatment of Metastatic Colorectal Cancer","author":"NCT00851045","year":"2009"},{"issue":"7","key":"10.1016\/B978-0-323-50878-0.00014-8_bib191","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano-bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib192","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jgm.773","article-title":"Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives","volume":"7","author":"Neu","year":"2005","journal-title":"J. Gene Med."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib193","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib194","first-page":"2131","article-title":"Folate receptor targeted delivery of liposomal daunorubicin into tumor cells","volume":"22","author":"Ni","year":"2002","journal-title":"Anticancer Res."},{"issue":"22","key":"10.1016\/B978-0-323-50878-0.00014-8_bib195","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1002\/pola.23036","article-title":"Block copolymer micelles conjugated with anti-EGFR antibody for targeted delivery of anticancer drug","volume":"46","author":"Noh","year":"2008","journal-title":"J. Polym. Sci. A Polym. Chem."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib196","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.09.010","article-title":"Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives","volume":"141","author":"Oh","year":"2010","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib197","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1021\/ja044941d","article-title":"Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells","volume":"127","author":"Oishi","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib198","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijpharm.2006.11.050","article-title":"Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes","volume":"331","author":"Oliveira","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/B978-0-323-50878-0.00014-8_bib199","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1073\/pnas.0910283107","article-title":"Activatable cell penetrating peptides linked to nanoparticles as dual probes for in\u00a0vivo fluorescence and MR imaging of proteases","volume":"107","author":"Olson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/B978-0-323-50878-0.00014-8_bib201","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib202","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jconrel.2004.01.002","article-title":"Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice","volume":"95","author":"Oyewumi","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.addr.2013.12.008","article-title":"Liposomal siRNA nanocarriers for cancer therapy","volume":"66","author":"Ozpolat","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib204","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1023\/A:1022219003551","article-title":"Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells","volume":"20","author":"Panyam","year":"2003","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp034002c","article-title":"Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles","volume":"1","author":"Panyam","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib206","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/IJN.S53432","article-title":"In\u00a0vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes","volume":"9","author":"Pappalardo","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"37","key":"10.1016\/B978-0-323-50878-0.00014-8_bib207","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1021\/bi00489a031","article-title":"Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA","volume":"29","author":"Parente","year":"1990","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib208","first-page":"1172","article-title":"Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery","volume":"8","author":"Park","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/B978-0-323-50878-0.00014-8_bib209","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1016\/j.biomaterials.2010.03.018","article-title":"Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate","volume":"31","author":"Park","year":"2010","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"49","key":"10.1016\/B978-0-323-50878-0.00014-8_bib211","doi-asserted-by":"crossref","first-page":"494002","DOI":"10.1088\/0957-4484\/22\/49\/494002","article-title":"Nanoparticles for intracellular-targeted drug delivery","volume":"22","author":"Paulo","year":"2011","journal-title":"Nanotechnology"},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib212","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/35074539","article-title":"Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER","volume":"3","author":"Pelkmans","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"5567","key":"10.1016\/B978-0-323-50878-0.00014-8_bib213","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.1069784","article-title":"Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae","volume":"296","author":"Pelkmans","year":"2002","journal-title":"Science"},{"issue":"24\u201325","key":"10.1016\/B978-0-323-50878-0.00014-8_bib214","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1016\/j.biomaterials.2008.04.038","article-title":"The effect of surface functionality on cellular trafficking of dendrimers","volume":"29","author":"Perumal","year":"2008","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib215","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/mp800024g","article-title":"Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor","volume":"5","author":"Platt","year":"2008","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib216","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/B:PHAM.0000022411.47059.76","article-title":"The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers","volume":"21","author":"Qaddoumi","year":"2004","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib217","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1021\/nn300240p","article-title":"Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier","volume":"6","author":"Qiao","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib218","series-title":"Nanobiomaterials in Drug Delivery","first-page":"1","article-title":"Chapter 1-Nanobiomaterials in drug delivery","author":"Rajabi","year":"2016"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib219","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2897","article-title":"Subcellular targeting strategies for drug design and delivery","volume":"9","author":"Rajendran","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib220","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ymthe.2005.03.038","article-title":"Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes","volume":"12","author":"Rejman","year":"2005","journal-title":"Mol. Ther."},{"issue":"Pt 1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib221","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib222","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biomaterials.2014.10.053","article-title":"CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses","volume":"40","author":"Rosalia","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib223","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cej.2016.11.122","article-title":"Carbon dot\/TAT peptide co-conjugated bubble nanoliposome for multicolor cell imaging, nuclear-targeted delivery, and chemo\/photothermal synergistic therapy","volume":"312","author":"Roya","year":"2017","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib224","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0945-053X(03)00083-0","article-title":"The RGD story: a personal account","volume":"22","author":"Ruoslahti","year":"2003","journal-title":"Matrix Biol."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib225","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/IJN.S40579","article-title":"Concepts and practices used to develop functional PLGA-based nanoparticulate systems","volume":"8","author":"Sah","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib226","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib227","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biomaterials.2009.09.101","article-title":"The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents","volume":"31","author":"Sahay","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib228","first-page":"585","article-title":"Organelle targeting: third level of drug targeting","volume":"7","author":"Sakhrani","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib229","doi-asserted-by":"crossref","first-page":"181646","DOI":"10.1155\/2011\/181646","article-title":"An overview on the field of micro- and nanotechnologies for synthetic peptide-based vaccines","volume":"2011","author":"Salvador","year":"2011","journal-title":"J. Drug Deliv."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2011.08.015","article-title":"EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity","volume":"157","author":"Sandoval","year":"2012","journal-title":"J. Control. Release"},{"issue":"15S","key":"10.1016\/B978-0-323-50878-0.00014-8_bib231","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1200\/jco.2009.27.15_suppl.2535","article-title":"A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin","volume":"27","author":"Sankhala","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib232","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.colsurfb.2014.06.003","article-title":"Rhodamine based plasmid DNA nanoparticles for mitochondrial gene therapy","volume":"121","author":"Santos","year":"2014","journal-title":"Colloids Surf. B"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib233","series-title":"Intracellular Delivery II: Fundamentals and Applications","first-page":"55","article-title":"Stimuli-responsive polymeric nanocarriers as promising drug and gene delivery systems","author":"Saravanakumar","year":"2014"},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib234","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s00216-008-2012-1","article-title":"An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives","volume":"391","author":"Sasaki","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib235","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2009.04.003","article-title":"Dynamics of magnetic lipoplexes studied by single particle tracking in living cells","volume":"137","author":"Sauer","year":"2009","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib236","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2006.10.020","article-title":"Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells","volume":"117","author":"Seib","year":"2007","journal-title":"J. Control. Release"},{"issue":"12 Suppl.","key":"10.1016\/B978-0-323-50878-0.00014-8_bib237","first-page":"C36","article-title":"Abstract C36: MBP-426, a novel liposome-encapsulated oxaliplatin, in combination with 5-FU\/leucovorin (LV): phase I results of a phase I\/II study in gastro-esophageal adenocarcinoma, with pharmacokinetics","volume":"8","author":"Senzer","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"26","key":"10.1016\/B978-0-323-50878-0.00014-8_bib238","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1016\/j.biomaterials.2011.05.014","article-title":"KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine","volume":"32","author":"Shaheen","year":"2011","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib239","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1073\/pnas.0804897106","article-title":"Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome","volume":"106","author":"Sharp","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib240","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1166\/jnn.2014.9082","article-title":"Endosomal escape: a bottleneck in intracellular delivery","volume":"14","author":"Shete","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib241","first-page":"1009","article-title":"Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles","volume":"29","author":"Shimada","year":"2009","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib242","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/bc200629f","article-title":"Dual peptide nucleic acid- and peptide-functionalized shell cross-linked nanoparticles designed to target mRNA toward the diagnosis and treatment of acute lung injury","volume":"23","author":"Shrestha","year":"2012","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib243","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib244","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2014.11.033","article-title":"In\u00a0vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model","volume":"198","author":"Silva","year":"2015","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2009.05.013","article-title":"pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells","volume":"381","author":"Simard","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"045013","key":"10.1016\/B978-0-323-50878-0.00014-8_bib246","article-title":"Intracellular localization of gold nanoparticles with targeted delivery in MT-4 lymphocytes","volume":"7","author":"Singh","year":"2016","journal-title":"Adv. Nat. Sci. Nanosci. Nanotechnol."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib247","series-title":"Intracellular Delivery","first-page":"57","article-title":"Approaches to achieving sub-cellular targeting of bioactives using pharmaceutical nanocarriers","author":"Solomon","year":"2011"},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib248","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nbt1101","article-title":"Antibody mediated in\u00a0vivo delivery of small interfering RNAs via cell-surface receptors","volume":"23","author":"Song","year":"2005","journal-title":"Nat. Biotechnol."},{"issue":"1\u20132","key":"10.1016\/B978-0-323-50878-0.00014-8_bib249","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2008.07.012","article-title":"Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in\u00a0vivo","volume":"363","author":"Song","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib250","doi-asserted-by":"crossref","first-page":"e29528","DOI":"10.4161\/tisb.29528","article-title":"Barriers to drug delivery in solid tumors","volume":"2","author":"Sriraman","year":"2014","journal-title":"Tissue Barriers"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib251","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.actbio.2015.11.029","article-title":"Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization","volume":"30","author":"Steinbach","year":"2016","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib252","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1021\/nn301164a","article-title":"Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG","volume":"6","author":"Suma","year":"2012","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib253","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nnano.2010.277","article-title":"Statistical analysis of nanoparticle dosing in a dynamic cellular system","volume":"6","author":"Summers","year":"2011","journal-title":"Nat. Nanotechnol."},{"issue":"15 Suppl.","key":"10.1016\/B978-0-323-50878-0.00014-8_bib254","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1200\/jco.2008.26.15_suppl.3523","article-title":"Phase I study of CT-322, first Adnectin protein therapeutic and potent inhibitor of VEGFR-2, in patients (pts) with advanced solid tumors (ST)","volume":"26","author":"Sweeney","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib255","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2005-01-0318","article-title":"Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody","volume":"106","author":"Tacken","year":"2005","journal-title":"Blood"},{"issue":"6\u20138","key":"10.1016\/B978-0-323-50878-0.00014-8_bib256","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.imbio.2006.05.021","article-title":"Targeting antigens to dendritic cells in\u00a0vivo","volume":"211","author":"Tacken","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib257","series-title":"European Conference on Biomedical Optics","article-title":"Lung cancer targeted Raman active phospholipid gold nanoparticles for ultrasensitive and specific molecular imaging and detection","author":"Tam","year":"2011"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib258","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2016.03.022","article-title":"How successful is nuclear targeting by nanocarriers?","volume":"229","author":"Tammam","year":"2016","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-50878-0.00014-8_bib259","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2013.07.069","article-title":"Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery","volume":"455","author":"Tanaka","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/B978-0-323-50878-0.00014-8_bib260","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/nnm.12.138","article-title":"Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher\u2019s cells in\u00a0vitro","volume":"8","author":"Thekkedath","year":"2013","journal-title":"Nanomedicine (Lond.)"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib261","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1091\/mbc.01-06-0317","article-title":"Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking","volume":"13","author":"Thomsen","year":"2002","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib262","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/1078-0432.CCR-10-1411","article-title":"Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin","volume":"17","author":"Tolcher","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/B978-0-323-50878-0.00014-8_bib263","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib264","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/bip.20989","article-title":"Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery","volume":"90","author":"Torchilin","year":"2008","journal-title":"Biopolymers"},{"issue":"4\u20135","key":"10.1016\/B978-0-323-50878-0.00014-8_bib265","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.addr.2007.10.008","article-title":"Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers","volume":"60","author":"Torchilin","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib266","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.2147\/IJN.S53636","article-title":"Drug-loading capacity and nuclear targeting of multiwalled carbon nanotubes grafted with anionic amphiphilic copolymers","volume":"8","author":"Tsai","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"4968","key":"10.1016\/B978-0-323-50878-0.00014-8_bib267","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"issue":"9","key":"10.1016\/B978-0-323-50878-0.00014-8_bib268","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1080\/10717544.2016.1199606","article-title":"Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles","volume":"23","author":"Tummala","year":"2016","journal-title":"Drug Deliv."},{"issue":"14","key":"10.1016\/B978-0-323-50878-0.00014-8_bib269","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"Pt 6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib270","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1042\/BST0361478","article-title":"C-type lectins on dendritic cells: key modulators for the induction of immune responses","volume":"36","author":"van Kooyk","year":"2008","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib271","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib272","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.addr.2007.06.003","article-title":"Biodegradable nanoparticles for cytosolic delivery of therapeutics","volume":"59","author":"Vasir","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib273","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/nnm.11.168","article-title":"Studying the in\u00a0vitro behavior of cationic solid lipid nanoparticles as a nonviral vector","volume":"7","author":"Vighi","year":"2012","journal-title":"Nanomedicine (Lond.)"},{"issue":"10","key":"10.1016\/B978-0-323-50878-0.00014-8_bib274","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.1074\/jbc.M110.186858","article-title":"Protein kinase C-dependent ubiquitination and clathrin-mediated endocytosis of the cationic amino acid transporter CAT-1","volume":"286","author":"Vina-Vilaseca","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib275","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib276","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1517\/14712598.8.8.1063","article-title":"Biofunctionalized targeted nanoparticles for therapeutic applications","volume":"8","author":"Wang","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib277","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.18632\/oncotarget.3090","article-title":"Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"26","key":"10.1016\/B978-0-323-50878-0.00014-8_bib278","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1016\/j.biomaterials.2014.05.050","article-title":"Matrix metalloproteinase 2-responsive micelle for siRNA delivery","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib279","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2005.07.004","article-title":"Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin","volume":"62","author":"Wang","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib280","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/mp1000229","article-title":"Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein","volume":"7","author":"Wang","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib281","first-page":"2513","article-title":"Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection","volume":"7","author":"Wang","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/B978-0-323-50878-0.00014-8_bib282","doi-asserted-by":"crossref","first-page":"980","DOI":"10.4161\/cbt.6.6.4197","article-title":"In\u00a0vitro efficacy of immuno-chemotherapy with anti-EGFR human Fab-Taxol conjugate on A431 epidermoid carcinoma cells","volume":"6","author":"Wang","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"49","key":"10.1016\/B978-0-323-50878-0.00014-8_bib283","doi-asserted-by":"crossref","first-page":"27140","DOI":"10.1021\/acsami.5b07557","article-title":"Bioinert anodic alumina nanotubes for targeting of endoplasmic reticulum stress and autophagic signaling: a combinatorial nanotube-based drug delivery system for enhancing cancer therapy","volume":"7","author":"Wang","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/B978-0-323-50878-0.00014-8_bib284","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/nn9012274","article-title":"Size and dynamics of caveolae studied using nanoparticles in living endothelial cells","volume":"3","author":"Wang","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib285","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev.biochem.68.1.611","article-title":"In\u00a0vitro selection of functional nucleic acids","volume":"68","author":"Wilson","year":"1999","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib286","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/bc0341674","article-title":"Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy","volume":"15","author":"Wu","year":"2004","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/B978-0-323-50878-0.00014-8_bib287","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.biomaterials.2012.08.072","article-title":"pH-sensitive poly(histidine)-PEG\/DSPE-PEG co-polymer micelles for cytosolic drug delivery","volume":"34","author":"Wu","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib288","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter?","volume":"40","author":"Xiang","year":"2006","journal-title":"Methods"},{"issue":"229","key":"10.1016\/B978-0-323-50878-0.00014-8_bib289","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.03.029","article-title":"Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma","volume":"10","author":"Xie","year":"2016","journal-title":"J. Control. Release"},{"issue":"59","key":"10.1016\/B978-0-323-50878-0.00014-8_bib290","first-page":"e3612","article-title":"Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles","author":"Xu","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib291","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbamem.2007.11.002","article-title":"MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion","volume":"1778","author":"Yamada","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib292","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/mt.2011.99","article-title":"Dual function MITO-Porter, a nano\u00a0carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery","volume":"19","author":"Yamada","year":"2011","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/B978-0-323-50878-0.00014-8_bib293","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.biomaterials.2011.10.082","article-title":"Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter","volume":"33","author":"Yamada","year":"2012","journal-title":"Biomaterials"},{"issue":"22","key":"10.1016\/B978-0-323-50878-0.00014-8_bib294","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1002\/smll.201401532","article-title":"Micro- and nanotechnologies for intracellular delivery","volume":"10","author":"Yan","year":"2014","journal-title":"Small"},{"issue":"14","key":"10.1016\/B978-0-323-50878-0.00014-8_bib295","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.biomaterials.2014.01.076","article-title":"PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy","volume":"35","author":"Yang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib296","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biomaterials.2015.01.030","article-title":"Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery","volume":"48","author":"Yang","year":"2015","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/B978-0-323-50878-0.00014-8_bib297","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3390\/ijms17111892","article-title":"CPP-assisted intracellular drug delivery, what is next?","volume":"17","author":"Ye","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/B978-0-323-50878-0.00014-8_bib298","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/smll.201100472","article-title":"Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles","volume":"7","author":"Yu","year":"2011","journal-title":"Small"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib299","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7150\/thno.3463","article-title":"Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy","volume":"2","author":"Yu","year":"2012","journal-title":"Theranostics"},{"issue":"423","key":"10.1016\/B978-0-323-50878-0.00014-8_bib300","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1063\/1.3625393","article-title":"Interrogation of EGFR targeted uptake of TiO2 nanoconjugates by X-ray fluorescence microscopy","volume":"1365","author":"Yuan","year":"2011","journal-title":"AIP Conf. Proc."},{"issue":"12","key":"10.1016\/B978-0-323-50878-0.00014-8_bib301","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.biomaterials.2012.12.031","article-title":"A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy","volume":"34","author":"Yuba","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib302","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(00)00358-8","article-title":"In\u00a0vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density","volume":"71","author":"Zauner","year":"2001","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib303","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpb.2010.05.005","article-title":"Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery","volume":"76","author":"Zhang","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/B978-0-323-50878-0.00014-8_bib304","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/med.20171","article-title":"Recent developments in carbohydrate-decorated targeted drug\/gene delivery","volume":"30","author":"Zhang","year":"2010","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/B978-0-323-50878-0.00014-8_bib305","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/toxsci\/kfp087","article-title":"Mechanisms of quantum dot nanoparticle cellular uptake","volume":"110","author":"Zhang","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"41","key":"10.1016\/B978-0-323-50878-0.00014-8_bib306","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1002\/adma.201102263","article-title":"Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy","volume":"23","author":"Zhang","year":"2011","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/B978-0-323-50878-0.00014-8_bib307","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1166\/jbn.2016.2278","article-title":"A pH-sensitive nanosystem based on carboxymethyl chitosan for tumor-targeted delivery of daunorubicin","volume":"12","author":"Zhang","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"issue":"3","key":"10.1016\/B978-0-323-50878-0.00014-8_bib308","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/smll.200901515","article-title":"HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting","volume":"6","author":"Zhang","year":"2010","journal-title":"Small"},{"issue":"22","key":"10.1016\/B978-0-323-50878-0.00014-8_bib309","doi-asserted-by":"crossref","first-page":"20290","DOI":"10.1021\/am505824d","article-title":"Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery","volume":"6","author":"Zhao","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib310","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1039\/C6TB02620F","article-title":"Multifunctional polyethylenimine-based nanoplatform for targeted anticancer drug delivery to tumors in\u00a0vivo","author":"Zhou","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib311","series-title":"Intracellular Delivery: Fundamentals and Applications","first-page":"97","article-title":"The potential and current progress of internalizing molecules in targeted drug delivery","author":"Zhou","year":"2011"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-50878-0.00014-8_bib312","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2015.03.081","article-title":"Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery","volume":"487","author":"Zhou","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-50878-0.00014-8_bib313","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bios.2013.12.003","article-title":"Targeted surface-functionalized gold nanoclusters for mitochondrial imaging","volume":"55","author":"Zhuang","year":"2014","journal-title":"Biosens. Bioelectron."},{"issue":"31","key":"10.1016\/B978-0-323-50878-0.00014-8_bib314","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Biomedical Applications of Functionalized Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323508780000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323508780000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T23:46:40Z","timestamp":1720136800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323508780000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780323508780"],"references-count":314,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-50878-0.00014-8","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}